Evidence map›Paper›PMID 37951902›Full record

ArticleBMC public health2023

Evaluation of the Acute flaccid paralysis surveillance indicators in Zambia from 2015-2021: a retrospective analysis.

Barnabas Bessing, Edward A Dagoe, Deborah Tembo, Alice Mwangombe, Muzala K Kanyanga, Fadinding Manneh, Belem B Matapo, Patricia M Bobo, Musole Chipoya, Victor A Eboh and 6 more

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 4 countries.

Barnabas BessingWorld Health Organization Country Office, Lusaka, Zambia. benabala1@gmail.com.
Edward A DagoeUnited States Centers for Disease Control and Prevention, Atlanta, USA.
Deborah TemboZambia National Public Health Institute, Lusaka, Zambia.
Alice MwangombeWorld Health Organization Country Office, Lusaka, Zambia.
Muzala K KanyangaZambia National Public Health Institute, Lusaka, Zambia.
Fadinding MannehWorld Health Organization Africa Regional Office, Congo Brazzaville, Republic of Congo.
Belem B MatapoWorld Health Organization Country Office, Lusaka, Zambia.
Patricia M BoboMinistry of Health Headquarters, Lusaka, Zambia.
Musole ChipoyaMcKing Consulting Corporation, Lusaka, Zambia.
Victor A EbohTaskforce for Global Health, Decatur GA, USA.
Princess L KayeyeMinistry of Health Headquarters, Lusaka, Zambia.
Penelope K MasumbuWorld Health Organization Country Office, Lusaka, Zambia.
Chilweza MuzongweMinistry of Health Headquarters, Lusaka, Zambia.
Nathan N BakyaitaWorld Health Organization Country Office, Lusaka, Zambia.
Delayo ZomahounUnited States Centers for Disease Control and Prevention, Atlanta, USA.
Jude N TumaUnited States Centers for Disease Control and Prevention, Atlanta, USA.
World Health Organization - Zambia · ZMMinistry of Health · ZMWorld Health Organization · CHZambia National Public Health Institute · ZMCenters for Disease Control and Prevention · USThe Task Force for Global Health · USWorld Health Organization Regional Office for Africa · CG

Funding

CDC HHSWorld Health Organization 001
6 · The paper itself

Abstract

backgroundThe resurgence of poliovirus infection in previously polio free regions and countries calls for renewed commitment to the global polio eradication efforts including strengthening of Acute Flaccid Paralysis (AFP) surveillance systems. Zambia is one of the countries substantially at risk for the importation of poliovirus infection from neighbouring countries including Malawi, Mozambique, and Democratic Republic of the Congo (DRC). This study describes a seven-year AFP surveillance, assesses the surveillance indicators, and highlights areas for improvement.

methodsWe conducted retrospective analysis of the routinely collected AFP surveillance data from January 2015 to December 2022. The AFP surveillance indicators performance was assessed using the World Health Organisation's recommended minimum AFP surveillance indicators performance.

resultsCumulatively, a total of 1715 AFP cases were reported over the study period. More than half, 891 (52%) of reported cases were aged < 5 years with 917 (53.5%) of males. More than half, 1186 (69.2%) had fever at onset, 718 (41.9%) had asymmetric paralysis and 1164 (67.9%) had their paralysis progressed within 3 days of onset. The non-polio AFP rate ranges from 3.4 to 6.4 per 100,000 children < 15 years old and stool adequacy ranging from 70.9% to 90.2% indicating sensitive surveillance with late detection of cases. The percentage of cases with early stool collection, timely transportation was above the World Health Organisation (WHO) minimum of 80% but with declining proportion of stools arriving in the laboratory in optimal condition. Completeness of 60-days follow-up evaluation was suboptimal ranging from 0.9% to 28.2%.

conclusionThe AFP surveillance system in Zambia is doing well. However, additional efforts are needed to improve early detection of cases; stool sample collection, transportation and monitoring to ensure arrival in good condition in the laboratory; and improve 60-days follow-up evaluation for evidenced-based classification of inadequate AFP cases and proper care.

Indexed as

PoliomyelitisPoliovirusAdolescentalpha-FetoproteinsCentral Nervous System Viral DiseasesChildHumansMaleMyelitisNeuromuscular DiseasesParalysisPopulation SurveillanceRetrospective StudiesZambiaalpha-FetoproteinsAcute Flaccid ParalysisIndicatorsPoliomyelitisSurveillanceZambia

Identifiers

PMID37951902
PMCPMC10640734
OpenAlexW4388599365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.